期刊文献+

替比夫定联合中草药治疗肝硬化门脉高压性胃病临床研究

Telbivudine clinical study of combined Chinese herbal medicine treatment of liver cirrhosis with portal hypertensive gastropathy
下载PDF
导出
摘要 目的讨论替比夫定联合中草药在治疗肝硬化门脉高压性胃病的临床运用价值。方法将本院2010年3月至2012年2月共收治的门脉高压性胃病患者160例随机分为2组。实验组采取替比夫定联合中草药的治疗方式,对照组采取单纯替比夫定治疗方法。经过1~3个疗程的治疗,通过胃镜检查等手段评价疗效。结果经过治疗,实验组的治愈、显效、有效例数分别为16、23、38例,总有效率为96.3%,与对照组的9、32、32、7和91.2%差异具有统计学意义(P<0.05)。胃镜检查结果则表明,替比夫定联合中草药可以有效促进症状消失与改善。结论替比夫定联合中草药治疗门脉高压性胃病较之单纯的使用替比夫定具有更好的疗效,值得在临床中进一步广泛推广。 Objective To discuss the to telbivudine joint Chinese herbal medicine use in the treatment of liver cirrhosis and portal hypertensive gastropathy clinical value.Methods 160 cases of portal hypertensive gastropathy in patients with I were treated in hospital in March 2010~2012 February were randomly divided into 2 groups.The experimental group take of telbivudine joint Chinese herbal medicine treatment,the control group to take the simple treatment of telbivudine.After 1-3 courses of treatment,evaluated by means of endoscopy and other.Results After treatment,cure of the experimental group,effective,effective cases were 16,23,38 cases,the total effective rate was 96.3%,9,32,32,7 and 91.2% of the control group there was significant difference P〈0.05.Gastroscopy showed that telbivudine joint Chinese herbal medicine can effectively promote the symptoms improve.Conclusion Telbivudine combined with Chinese herbal treatment of portal hypertensive gastropathy telbivudine has superior efficacy compared with the simple use,it is worth further clinical widely.
作者 张宗超
出处 《中国实用医药》 2012年第27期6-7,共2页 China Practical Medicine
关键词 替比夫定 健肝愈胃汤 中西医结合 PHG Telbivudine Liver invigorating the stomach soup Combination of Chinese traditional and Western Medicine PHG
  • 相关文献

参考文献5

二级参考文献19

  • 1孙政,杨镇.门静脉高压症胃病[J].临床外科杂志,2003,11(S1):75-76. 被引量:1
  • 2张晓慧.门脉高压性胃病上消化道出血85例分析[J].新乡医学院学报,2004,21(5):415-416. 被引量:1
  • 3肝硬化临床诊断、中医辨证和疗效评定标准(试行方案)[J].中国中西医结合杂志,1994,14(4):237-238. 被引量:347
  • 4钱云,姒健敏,吴加国.替普瑞酮对实验性胃溃疡愈合质量的影响[J].中华消化杂志,2005,25(7):431-432. 被引量:23
  • 5Tanoue K, Hashizume M, WedaH, et al. Effects of endoscopic injection selerotherapy on portal hypertensive gastropathy:a prospectiveudy[J]. Gastrointest Endosc, 1992,38(5) :582 - 585.
  • 6Soin AS, Acharya SK, Mathur M, et al. Portal hypertensive gastropathy in noncir-rhotic patients. The effect of lienorenal shunts [J]. J Clin Gastroenterol, 1998,26(6) :64 - 67.
  • 7Primignani M,Carpinelli L,Preatoni P,et al.Natural history of portal hypertensive gastropathy in patients with liver cirrhosis.Gastroenterology,2000,119:181-187.
  • 8La-zaratos S,Kashimura H,Nakahara A,et al.Gastric ulcer induced by submucosal injection of ET-1:role of Potent vasoconstriction and intraluminal acid.Am J Physiol,1993,265:491-498.
  • 9Filep JG,Sirois MG,Foldes-Filep E,et al.Enhancement by endothelin-1 of microvascular Permeability via the activation of ET Arece Ptors.Br J Pharmaeol,1993,109:880-886.
  • 10Migohs,Hashizume M,Tsugawa K,et al.Role of endothelin-1 in congestive gastroPathy in Portal hy-Pertensive rats.J Gastroenterol HePatol,2000,15:142-147.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部